IMPORTANT WARNING:
Tolvaptan (Samsca) may cause the level of sodium in your blood to increase too quickly. This may cause osmotic demyelination syndrome (ODS; serious nerve damage that may be caused by quick increases in sodium levels). Tell your doctor if you drink or have ever drunk large amounts of alcohol, if you have malnutrition (the body lacks the nutrients needed for good health), and if you have or have ever had liver disease or extremely low levels of sodium in your blood.
You and your doctor will take certain precautions to try to prevent ODS. You will begin your treatment with tolvaptan (Samsca) in the hospital so that your doctor can monitor you closely. If your doctor tells you to continue taking tolvaptan (Samsca) after you leave the hospital, you should not stop and re-start treatment on your own. You will need to return to the hospital when you restart the medication.
You will need to drink water whenever you are thirsty to help prevent ODS during your treatment with tolvaptan (Samsca) . Your doctor will not prescribe tolvaptan (Samsca) if you are unable to feel that you are thirsty. You should have drinking water available at all times during your treatment.
If you experience any of the following symptoms of ODS, tell your doctor immediately: difficulty speaking, difficulty swallowing, feeling that food or drinks are getting stuck in your throat, drowsiness, confusion, mood changes, body movements that are difficult to control, weakness of the arms or legs, or seizures.
You should know that tolvaptan is also available as a tablet (Jynarque) to slow the worsening of kidney function in adults with a certain type of inherited kidney disease. If you have this kidney disease, you should not take tolvaptan (Samsca). Because of the risk of liver problems with tolvaptan, Jynarque is available only through a special restricted distribution program. This monograph only gives information about tolvaptan tablets (Samsca) to treat low levels of sodium in the blood. If you are using this medication to slow the worsening of your kidney function, read the monograph entitled tolvaptan (kidney disease).
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with tolvaptan and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.
Talk to your doctor about the risk of taking tolvaptan (Samsca).